Theoretical models of AD pathophysiology suggest a sequential association of events in which tau pathology would precede neuronal dysfunction (as identified by [18F]FDG PET) that would further affect downstream cognitive processes [20]. This evidence concerns the gene MAPT and Alzheimer disease.